Es gab 50 kürzliche Insider-Transaktionen für Akebia Therapeutics, Inc. (AKBA), darunter 28 Käufe und 19 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $7.92M und die gesamten Insider-Verkäufe auf $1.28M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Vickers Philip J., Butler John P., Burke Steven Keith. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — AKBA
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-04-01 |
Vickers Philip J. |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2026-04-01 |
Vickers Philip J. |
Director |
RSU-Zuteilung |
214,400 |
$1.41 |
$302.3K |
214,400 |
| 2026-03-04 |
Butler John P. |
CEO and President |
Informierter Kauf |
69,270 |
$1.25 |
$86.59K |
3,367,064 |
| 2026-02-02 |
Butler John P. |
CEO and President |
Informierter Verkauf |
114,891 |
$1.39 |
$159.7K |
3,206,233 |
| 2026-02-02 |
Burke Steven Keith |
SVP, Chief Medical Officer |
Informierter Verkauf |
20,701 |
$1.39 |
$28.77K |
948,432 |
| 2026-02-02 |
Grund Nicholas |
Chief Commercial Officer |
Informierter Verkauf |
31,244 |
$1.39 |
$43.43K |
561,750 |
| 2026-02-02 |
Ostrowski Erik |
SVP, CFO, Cbo & Treasurer |
Informierter Verkauf |
34,951 |
$1.39 |
$48.58K |
672,635 |
| 2026-02-02 |
Malabre Richard C |
SVP, Chief Accounting Officer |
Informierter Verkauf |
13,382 |
$1.39 |
$18.6K |
299,390 |
| 2026-02-02 |
Rucci Carolyn M. |
SVP, Chief Legal Officer |
Informierter Verkauf |
27,544 |
$1.39 |
$38.29K |
588,378 |
| 2026-01-30 |
Butler John P. |
CEO and President |
RSU-Zuteilung |
1,115,000 |
$1.41 |
$1.57M |
1,115,000 |
| 2026-01-30 |
Burke Steven Keith |
SVP, Chief Medical Officer |
RSU-Zuteilung |
320,000 |
$1.41 |
$451.2K |
320,000 |
| 2026-01-30 |
Grund Nicholas |
Chief Commercial Officer |
RSU-Zuteilung |
320,000 |
$1.41 |
$451.2K |
320,000 |
| 2026-01-30 |
Ostrowski Erik |
SVP, CFO, Cbo & Treasurer |
RSU-Zuteilung |
320,000 |
$1.41 |
$451.2K |
320,000 |
| 2026-01-30 |
Malabre Richard C |
SVP, Chief Accounting Officer |
RSU-Zuteilung |
119,000 |
$1.41 |
$167.79K |
119,000 |
| 2026-01-30 |
Rucci Carolyn M. |
SVP, Chief Legal Officer |
RSU-Zuteilung |
270,000 |
$1.41 |
$380.7K |
270,000 |
| 2026-01-26 |
Rucci Carolyn M. |
SVP, Chief Legal Officer |
Unbekannt |
61,000 |
$2.88 |
$175.68K |
- |
| 2025-06-30 |
Ostrowski Erik |
SVP, CFO, Cbo & Treasurer |
Informierter Verkauf |
41,314 |
$3.67 |
$151.62K |
503,586 |
| 2025-06-10 |
Zumwalt Leanne M |
Director |
RSU-Zuteilung |
53,600 |
$3.92 |
$210.11K |
53,600 |
| 2025-06-10 |
Rogers Michael W |
Director |
RSU-Zuteilung |
53,600 |
$3.92 |
$210.11K |
53,600 |
| 2025-06-10 |
Adams Adrian |
Director |
RSU-Zuteilung |
53,600 |
$3.92 |
$210.11K |
53,600 |
| 2025-06-10 |
Gilman Steven C |
Director |
RSU-Zuteilung |
53,600 |
$3.92 |
$210.11K |
53,600 |
| 2025-06-10 |
Smith Cynthia |
Director |
RSU-Zuteilung |
53,600 |
$3.92 |
$210.11K |
53,600 |
| 2025-06-10 |
Wolf Myles |
Director |
RSU-Zuteilung |
53,600 |
$3.92 |
$210.11K |
53,600 |
| 2025-06-10 |
Frieson Ron |
Director |
RSU-Zuteilung |
53,600 |
$3.92 |
$210.11K |
53,600 |
| 2025-06-09 |
Malabre Richard C |
SVP, Chief Accounting Officer |
Informierter Verkauf |
15,000 |
$4.01 |
$60.15K |
266,914 |
| 2025-06-04 |
Malabre Richard C |
SVP, Chief Accounting Officer |
Informierter Verkauf |
13,334 |
$3.53 |
$47.07K |
266,914 |
| 2025-03-03 |
Butler John P. |
CEO and President |
Informierter Verkauf |
46,409 |
$1.83 |
$84.93K |
2,557,921 |
| 2025-03-03 |
Burke Steven Keith |
SVP, Chief Medical Officer |
Informierter Verkauf |
7,144 |
$1.83 |
$13.07K |
809,090 |
| 2025-02-03 |
Butler John P. |
CEO and President |
Informierter Verkauf |
97,982 |
$2.10 |
$205.76K |
2,604,330 |
| 2025-02-03 |
Burke Steven Keith |
SVP, Chief Medical Officer |
Informierter Verkauf |
27,236 |
$2.10 |
$57.2K |
816,234 |
| 2025-02-03 |
Grund Nicholas |
Chief Commercial Officer |
Informierter Verkauf |
55,621 |
$2.10 |
$116.8K |
442,579 |
| 2025-02-03 |
Malabre Richard C |
SVP, Chief Accounting Officer |
Informierter Verkauf |
30,202 |
$2.10 |
$63.42K |
280,248 |
| 2025-01-31 |
Butler John P. |
CEO and President |
RSU-Zuteilung |
350,500 |
- |
- |
350,500 |
| 2025-01-31 |
Burke Steven Keith |
SVP, Chief Medical Officer |
RSU-Zuteilung |
292,300 |
$2.24 |
$654.75K |
292,300 |
| 2025-01-31 |
Grund Nicholas |
Chief Commercial Officer |
RSU-Zuteilung |
292,300 |
$2.24 |
$654.75K |
292,300 |
| 2025-01-31 |
Ostrowski Erik |
SVP, CFO, Cbo & Treasurer |
RSU-Zuteilung |
292,300 |
$2.24 |
$654.75K |
292,300 |
| 2025-01-31 |
Malabre Richard C |
SVP, Chief Accounting Officer |
RSU-Zuteilung |
128,000 |
$2.24 |
$286.72K |
128,000 |
| 2025-01-17 |
Frieson Ron |
Director |
Optionsausübung (Verkauf) |
20,100 |
$0.45 |
$9.05K |
- |
| 2024-06-28 |
Ostrowski Erik |
SVP, CFO, Cbo & Treasurer |
RSU-Zuteilung |
350,000 |
- |
- |
350,000 |
| 2024-06-24 |
Ostrowski Erik |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-06-06 |
Zumwalt Leanne M |
Director |
RSU-Zuteilung |
45,000 |
$1.07 |
$48.15K |
45,000 |
| 2024-06-06 |
Rogers Michael W |
Director |
RSU-Zuteilung |
45,000 |
$1.07 |
$48.15K |
45,000 |
| 2024-06-06 |
Adams Adrian |
Director |
RSU-Zuteilung |
45,000 |
$1.07 |
$48.15K |
45,000 |
| 2024-06-06 |
Gilman Steven C |
Director |
RSU-Zuteilung |
45,000 |
$1.07 |
$48.15K |
45,000 |
| 2024-06-06 |
Smith Cynthia |
Director |
RSU-Zuteilung |
45,000 |
$1.07 |
$48.15K |
45,000 |
| 2024-06-06 |
Wolf Myles |
Director |
RSU-Zuteilung |
45,000 |
$1.07 |
$48.15K |
45,000 |
| 2024-06-06 |
Frieson Ron |
Director |
RSU-Zuteilung |
45,000 |
$1.07 |
$48.15K |
45,000 |
| 2024-05-13 |
Hadas Nicole R. |
SVP, Chief Legal Officer |
Informierter Verkauf |
12,016 |
$1.26 |
$15.14K |
651,243 |
| 2024-05-13 |
Dahan Michel |
SVP, Chief Operating Officer |
Informierter Verkauf |
34,840 |
$1.26 |
$43.9K |
672,092 |
| 2024-02-29 |
Butler John P. |
CEO and President |
Informierter Verkauf |
46,570 |
$1.58 |
$73.58K |
2,044,580 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
